Minimal important differences and response shift in health-related quality of life; a longitudinal study in patients with multiple myeloma

Overview of attention for article published in Health and Quality of Life Outcomes, August 2010

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 54 Dimensions

Readers on

mendeley: 79 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 4 policy documents that reference this research output.

ciltacabtagene autoleucel

Cited by Canadian Agency for Drugs and Technologies in Health on 02 Aug 2023

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

selinexor

Cited by Canadian Agency for Drugs and Technologies in Health on 12 Oct 2022

isatuximab

Cited by Canadian Agency for Drugs and Technologies in Health on 08 Apr 2022

idecabtagene vicleucel

Cited by Canadian Agency for Drugs and Technologies in Health on 02 Feb 2022

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.